Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.270
+0.040 (1.79%)
At close: Dec 5, 2025, 4:00 PM EST
2.140
-0.130 (-5.73%)
After-hours: Dec 5, 2025, 7:53 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '10 2013 - 2019
Vision Performance and Health
10.99M
Log In
Log In
Log In
Log In
Upgrade
Vision Performance and Health Growth
-42.30%
Log In
Log In
Log In
Log In
Upgrade
Innovative Treatments
-
Log In
Log In
Log In
Log In
Upgrade
Innovative Treatments Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '10 2013 - 2019
United States
10.99M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-42.30%
Log In
Log In
Log In
Log In
Upgrade